Thermo Fisher Scientific (TMO) Inventory Average (2012 - 2026)

Thermo Fisher Scientific (TMO) has reported Inventory Average for 15 consecutive years, with $5.6 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average rose 3.15% year-over-year to $5.6 billion; the trailing twelve-month figure through Jun 2026 stood at $5.6 billion (up 3.15% YoY), and the FY2025 full-year result was $5.2 billion, up 3.35% from the prior year.
• Inventory Average grew to $5.6 billion in Q2 2026 per TMO's latest filing, from $5.5 billion in the prior quarter.
• Across five years, Inventory Average topped out at $5.7 billion in Q4 2022 and bottomed at $5.1 billion in Q1 2025.
• Historically, Inventory Average has averaged $5.4 billion across 5 years, with a median of $5.5 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Inventory Average grew 25.84% in 2022, then decreased 9.53% in 2024.
• Over 5 years, Inventory Average stood at $5.7 billion in 2022, then slipped by 7.61% to $5.2 billion in 2023, then retreated by 0.8% to $5.2 billion in 2024, then grew by 7.32% to $5.6 billion in 2025, then decreased by 0.42% to $5.6 billion in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $5.6 billion, $5.5 billion, and $5.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.